DK1828166T3 - Hydantoinderivater, der kan anvendes som metalloproteinase-inhibitorer - Google Patents

Hydantoinderivater, der kan anvendes som metalloproteinase-inhibitorer

Info

Publication number
DK1828166T3
DK1828166T3 DK05818265T DK05818265T DK1828166T3 DK 1828166 T3 DK1828166 T3 DK 1828166T3 DK 05818265 T DK05818265 T DK 05818265T DK 05818265 T DK05818265 T DK 05818265T DK 1828166 T3 DK1828166 T3 DK 1828166T3
Authority
DK
Denmark
Prior art keywords
metalloproteinase inhibitors
hydantoin derivatives
hydantoin
derivatives
metalloproteinase
Prior art date
Application number
DK05818265T
Other languages
Danish (da)
English (en)
Inventor
David Waterson
David J Persson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK1828166T3 publication Critical patent/DK1828166T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41661,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK05818265T 2004-12-15 2005-12-14 Hydantoinderivater, der kan anvendes som metalloproteinase-inhibitorer DK1828166T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0427403.1A GB0427403D0 (en) 2004-12-15 2004-12-15 Novel compounds I
PCT/GB2005/004811 WO2006064218A1 (en) 2004-12-15 2005-12-14 Hydantoin derivatives useful as metalloproteinase inhibitors

Publications (1)

Publication Number Publication Date
DK1828166T3 true DK1828166T3 (da) 2009-10-05

Family

ID=34090044

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05818265T DK1828166T3 (da) 2004-12-15 2005-12-14 Hydantoinderivater, der kan anvendes som metalloproteinase-inhibitorer

Country Status (30)

Country Link
US (1) US8129412B2 (el)
EP (1) EP1828166B1 (el)
JP (1) JP5042849B2 (el)
KR (1) KR20070090921A (el)
CN (1) CN101080402B (el)
AR (1) AR051797A1 (el)
AU (1) AU2005315459B2 (el)
BR (1) BRPI0519057A2 (el)
CA (1) CA2589525A1 (el)
CY (1) CY1109376T1 (el)
DE (1) DE602005015617D1 (el)
DK (1) DK1828166T3 (el)
ES (1) ES2328836T3 (el)
GB (1) GB0427403D0 (el)
HK (1) HK1108435A1 (el)
HR (1) HRP20090489T1 (el)
IL (1) IL183590A0 (el)
MX (1) MX2007006744A (el)
NO (1) NO20073550L (el)
NZ (1) NZ555684A (el)
PL (1) PL1828166T3 (el)
PT (1) PT1828166E (el)
RS (1) RS51193B (el)
RU (1) RU2388758C2 (el)
SA (1) SA05260406B1 (el)
SI (1) SI1828166T1 (el)
TW (1) TW200634001A (el)
UA (1) UA89067C2 (el)
WO (1) WO2006064218A1 (el)
ZA (1) ZA200705068B (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2381452T3 (es) 2007-10-19 2012-05-28 Boehringer Ingelheim International Gmbh PIPERIDINO-DIHIDROTIENOPIRIMIDINAS sustituidas
WO2009138777A1 (en) * 2008-05-12 2009-11-19 Astrazeneca Ab Process for the preparation of alkoxy-phenoxy-pi peridine
US7759512B2 (en) 2008-07-21 2010-07-20 3M Innovative Properties Company Aqueous methods for making fluorinated sulfonate esters
CN102234287B (zh) 2010-04-26 2015-08-05 上海阳帆医药科技有限公司 硝基咪唑类化合物、其制备方法和用途
US9255074B2 (en) 2010-07-16 2016-02-09 Abbvie Inc. Process for preparing antiviral compounds
KR101774742B1 (ko) 2010-07-16 2017-09-11 애브비 아일랜드 언리미티드 컴퍼니 촉매 반응용 포스핀 리간드
US8975443B2 (en) 2010-07-16 2015-03-10 Abbvie Inc. Phosphine ligands for catalytic reactions
JP5819959B2 (ja) 2010-07-16 2015-11-24 アッヴィ・バハマズ・リミテッド 抗ウイルス性化合物を調製するための方法
HUP1300139A2 (en) 2013-03-06 2014-09-29 Richter Gedeon Nyrt Phenoxypiperidine h3 antagonists
US20160364553A1 (en) * 2015-06-09 2016-12-15 Intel Corporation System, Apparatus And Method For Providing Protected Content In An Internet Of Things (IOT) Network
GB201610056D0 (en) * 2016-06-09 2016-07-27 Galapagos Nv And Laboratoires Servier Les Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders and osteoarthritis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9919776D0 (en) * 1998-08-31 1999-10-27 Zeneca Ltd Compoujnds
EP1187811B1 (en) * 1999-06-04 2007-03-07 AstraZeneca AB Inhibitors of metalloproteinases
RU2283306C2 (ru) 2000-02-21 2006-09-10 Астразенека Аб Пиперидин- и пиперазинзамещенные n-гидроксиформамиды в качестве ингибиторов металлопротеиназ
SE0100902D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0301922D0 (sv) * 2003-06-27 2003-06-27 Astrazeneca Ab Novel compounds

Also Published As

Publication number Publication date
UA89067C2 (ru) 2009-12-25
TW200634001A (en) 2006-10-01
AU2005315459B2 (en) 2009-01-08
NZ555684A (en) 2009-11-27
ZA200705068B (en) 2008-10-29
US20080280950A1 (en) 2008-11-13
JP5042849B2 (ja) 2012-10-03
SA05260406B1 (ar) 2009-02-02
WO2006064218A1 (en) 2006-06-22
MX2007006744A (es) 2007-07-09
RU2007121222A (ru) 2009-01-27
ES2328836T3 (es) 2009-11-18
NO20073550L (no) 2007-09-11
CN101080402A (zh) 2007-11-28
DE602005015617D1 (de) 2009-09-03
EP1828166A1 (en) 2007-09-05
CA2589525A1 (en) 2006-06-22
SI1828166T1 (sl) 2009-12-31
US8129412B2 (en) 2012-03-06
CN101080402B (zh) 2010-12-08
IL183590A0 (en) 2007-09-20
RS51193B (sr) 2010-10-31
JP2008524184A (ja) 2008-07-10
HRP20090489T1 (hr) 2009-10-31
AU2005315459A1 (en) 2006-06-22
GB0427403D0 (en) 2005-01-19
EP1828166B1 (en) 2009-07-22
CY1109376T1 (el) 2014-07-02
RU2388758C2 (ru) 2010-05-10
BRPI0519057A2 (pt) 2008-12-23
PT1828166E (pt) 2009-09-16
AR051797A1 (es) 2007-02-07
PL1828166T3 (pl) 2009-12-31
KR20070090921A (ko) 2007-09-06
HK1108435A1 (en) 2008-05-09

Similar Documents

Publication Publication Date Title
LTC1907382I2 (lt) Nitrokatechnolio dariniai, kaip COMT inhibitoriai
DK1828166T3 (da) Hydantoinderivater, der kan anvendes som metalloproteinase-inhibitorer
DK1789041T3 (da) Aryl-pyridinderivater som 11-beta-HSD1-inhibitorer
DK1797042T3 (da) Indozolonderivater som 11B-HSD1-inhibitorer
DK1940813T3 (da) Heterocykliske amidderivater, der kan anvendes som mikrobiocider
DK1740569T3 (da) Imidazol-derivater som TAFla-inhibitorer
DK2094263T3 (da) 2-adamantyl-butyramidderivater som selektive 11 beta-hsd1-inhibitorer
DK1846394T3 (da) Pyrazolylaminopyridinderivater, der er egnede som kinaseinhibitorer
NO20053775D0 (no) Diazepinoindol derivater som kinaseinhibitorer.
DK1492785T3 (da) 2-hydroxy-3-heteroarylindol-derivater som GSK3-inhibitorer
DK1960352T3 (da) 2-adamantylurinstof-derivater som selektive 11beta-hsd1 inhibitorer
DK1926722T3 (da) Substituerede benzimidazoler som kinaseinhibitorer
DK1586319T3 (da) Thiadiazolidinoner som GSK-3-inhibitorer
DK1959951T3 (da) Heteroaryl-substituerede piperidinderivater som L-CPT1-inhibitorer
DK1962830T3 (da) Azaindolhæmmere af aurorakinaser.
DK1763517T3 (da) Pyrimidinderivater som 11beta-HSD1-inhibitorer
DK2086939T3 (da) Pyridiacarboxamid som II-beta-HSDI-inhibitorer
DK1979356T3 (da) Carbonylaminopyrrolopyrazoler, kraftige kinaseinhibitorer
ATE538092T1 (de) Asparaginsäureproteaseinhibitoren
DK2125748T3 (da) Acylaminopyrazol som FGFR inhibitorer
DK2078001T3 (da) Diazepan-acetamidderivater som selektive 11-HSD1-inhibitorer
NO20051236L (no) Heterobiarylderivater som matriksmetalloproteinaseinhibitorer
DK1711177T3 (da) 1H-thieno-2,3-c-pyrazolderivater, der er egnede som kinase-I-inhibitorer
ZA200705075B (en) Novel hydantoin derivatives as metalloproteinase inhibitors
DK1954690T3 (da) Benzamidforbindelser, der er anvendelige som inhibitorer af histondeacetylase